AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Ep. 214 Ken Shreve: Improving Portfolio Health With Medical Stocks
Investing With IBD
How to Avoid Speculative Names in Biotechs
Rousha: Is there anything that you do to kind of just make sure you're dealing with higher quality and the less, you know, a little bit lower risk? Rousha: One of the first areas that I start to go through on the weekends is the marksman growth to 50. That's just casting a wide enough net. And what I'll look there, you'll just start seeing the higher quality names within a biotech or medical products starting to come into those screens.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode